Literature DB >> 11574788

Triglycerides: risk factor or fellow traveler?

J S Forrester1.   

Abstract

An unresolved issue in preventive cardiology is whether the serum triglyceride level is an independent risk factor for coronary heart disease and, as a direct practical consequence, whether it has value as a diagnostic test. Evidence published in the past year has contributed substantially to clarifying these issues. In this review, we discuss the data that bears upon the importance of triglycerides as a risk factor and the implications of recent clinical trials directed at lipid lowering. We then discuss the alternatives for triglyceride lowering therapy in the light of this new knowledge.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11574788     DOI: 10.1097/00001573-200107000-00007

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  10 in total

1.  INSIG1 influences obesity-related hypertriglyceridemia in humans.

Authors:  E M Smith; Y Zhang; T M Baye; S Gawrieh; R Cole; J Blangero; M A Carless; J E Curran; T D Dyer; L J Abraham; E K Moses; A H Kissebah; L J Martin; M Olivier
Journal:  J Lipid Res       Date:  2009-10-21       Impact factor: 5.922

2.  Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR.

Authors:  Yanqiao Zhang; Lawrence W Castellani; Christopher J Sinal; Frank J Gonzalez; Peter A Edwards
Journal:  Genes Dev       Date:  2004-01-16       Impact factor: 11.361

3.  Polymorphism of apolipoprotein A5 is a risk factor for cerebral infarction in type 2 diabetes.

Authors:  Xuefeng Li; Yancheng Xu; Yan Ding; Chengming Qin; Zhe Dai; Li Niu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-12-24

4.  PPARdelta is a very low-density lipoprotein sensor in macrophages.

Authors:  Ajay Chawla; Chih-Hao Lee; Yaacov Barak; Weimin He; John Rosenfeld; Debbie Liao; Jungyeob Han; Heonjoong Kang; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-22       Impact factor: 11.205

5.  Apolipoprotein A-V variant (T-1131>C) affects plasma levels of non-high-density lipoprotein cholesterol in Caucasians.

Authors:  Jaroslav A Hubacek; Zdena Skodová; Vera Lánská; Vera Adámková
Journal:  Exp Clin Cardiol       Date:  2008

6.  Association of APOA5 rs662799 and rs3135506 polymorphisms with arterial hypertension in Moroccan patients.

Authors:  Sanaa Ouatou; Maria Ajjemami; Hicham Charoute; Hajar Sefri; Noreddine Ghalim; Houria Rhaissi; Houda Benrahma; Abdelhamid Barakat; Hassan Rouba
Journal:  Lipids Health Dis       Date:  2014-04-01       Impact factor: 3.876

7.  Postprandial Hypertriglyceridemia Is Associated with the Variant 54 Threonine FABP2 Gene.

Authors:  María Fatima Garcés Da Silva; Yamil Adrian Guarin; Yenny Carrero; Hilda Stekman; María Luisa Núñez Bello; Celsy Hernández; Rafael Apitz; Mercedes Fernández-Mestre; Germán Camejo
Journal:  J Cardiovasc Dev Dis       Date:  2018-09-13

8.  The association between APOA5 haplotypes and plasma lipids is not modified by energy or fat intake: the Czech HAPIEE study.

Authors:  J A Hubacek; A Peasey; R Kubinova; H Pikhart; M Bobak
Journal:  Nutr Metab Cardiovasc Dis       Date:  2013-10-09       Impact factor: 4.222

9.  Association of G894T eNOS, 4G/5G PAI and T1131C APOA5 polymorphisms with susceptibility to myocardial infarction in Morocco.

Authors:  Hind Hassani Idrissi; Wiam Hmimech; Brehima Diakite; Farah Korchi; Dalila Baghdadi; Rachida Habbal; Sellama Nadifi
Journal:  Meta Gene       Date:  2016-04-03

10.  Association of apolipoprotein E gene polymorphisms with blood lipids and their interaction with dietary factors.

Authors:  Israa M Shatwan; Kristian Hillert Winther; Basma Ellahi; Peter Elwood; Yoav Ben-Shlomo; Ian Givens; Margaret P Rayman; Julie A Lovegrove; Karani S Vimaleswaran
Journal:  Lipids Health Dis       Date:  2018-04-30       Impact factor: 3.876

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.